FDA Brief

Warning letters Drugs

FDA warning letter to

Optikem International Inc.

Issued Jun 20, 2024Posted Jul 9, 2024Division of Pharmaceutical Quality Operations IV

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Optikem International Inc.'s FDA history

  1. Optikem International, Inc.

    CGMP/QSR/Medical Devices/Adulterated

Full company page